Consumption of prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis has minor effects on selected immune parameters in polypectomised and colon cancer patients

British Journal of Nutrition

Volumn 97, Issue 4, 2007, Pages 676-684

  Roller, Monika ^a   Clune, Yvonne ^b   Collins, Kevin ^b,c   Rechkemmer, Gerhard ^a,d   Watzl, Bernhard ^a  

^a FEDERAL RESEARCH INSTITUTE OF NUTRITION AND FOOD   (Germany)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c UNIVERSITY COLLEGE CORK   (Ireland)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Human; Immune system; Prebiotic; Probiotic; Randomised double blind placebo controlled trial; Synbiotic

Indexed keywords

BIFIDOBACTERIUM ANIMALIS EXTRACT; FRUCTOSE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INULIN; LACTOBACILLUS RHAMNOSUS EXTRACT; MALTODEXTRIN; PLACEBO; PROBIOTIC AGENT; PROSTAGLANDIN E2; RAFTILOSE SYNERGY1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BIFIDOBACTERIUM ANIMALIS; CANCER PATIENT; CELL ACTIVATION; CLINICAL TRIAL; COLON CANCER; COLON RESECTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FECES LEVEL; FEMALE; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOSTIMULATION; LACTOBACILLUS RHAMNOSUS; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NATURAL KILLER CELL; NEUTROPHIL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTOSIS; POLYPECTOMY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY BURST; STATISTICAL SIGNIFICANCE; TUMOR IMMUNITY;

AGED; BIFIDOBACTERIUM; CELLS, CULTURED; COLONIC NEOPLASMS; COLONIC POLYPS; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INULIN; KILLER CELLS, NATURAL; LACTOBACILLUS RHAMNOSUS; MALE; MIDDLE AGED; OLIGOSACCHARIDES; PHAGOCYTOSIS; PROBIOTICS; RESPIRATORY BURST;

BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS; LACTOBACILLUS RHAMNOSUS;

EID: 33947542115     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114507450292     Document Type: Article

References (50)

1. Arunachalam K, Gill HS & Chandra RK (2000) Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019). Eur J Clin Nutr 54, 263-267.
2. Bourlioux P, Koletzko B, Guarner F & Braesco V (2003) The intestine and its microflora are partners for the protection of the host: Report on the Danone Symposium 'The Intelligent Intestine', held in Paris, June 14, 2002. Am J Clin Nutr 78, 675-683.
3. Bunout D, Hirsch S, Pia de la Maza M, Munoz C, Haschke F, Steenhout P, Klassen P, Barrera G, Gattas V & Petermann M (2002) Effects of prebiotics on the immune response to vaccination in the elderly. J Parenter Enteral Nutr 26, 372-376.
4. Burns AJ & Rowland IR (2000) Anti-carcinogenicity of probiotics and prebiotics. Curr Issues Intest Microbiol 1, 13-24.
5. Campieri M & Gionchetti P (1999) Probiotics in inflammatory bowel disease: New insight to pathogenesis or a possible therapeutic alternative? Gastroenterology 116, 1246-1249.
6. Chang L, Gusewitch GA, Chritton DB, Folz JC, Lebeck LK & Nehlsen-Cannarella SL (1993) Rapid flow cytometric assay for the assessment of natural killer cell activity. J Immunol Methods 166, 45-54.
7. Chapman MA (2001) The role of the colonic flora in maintaining a healthy large bowel mucosa. Ann R Coll Surg Engl 83, 75-80.
8. Chiang BL, Sheih YH, Wang LH, Liao CK & Gill HS (2000) Enhancing immunity by dietary consumption of a probiotic lactic acid bacterium (Rifidobacterium lactis HN019): Optimization and definition of cellular immune responses. Eur J Clin Nutr 54, 849-855.
9. Christensen HR, Nexmann Larson C, Kæstel P, Buus Rosholm L, Sternberg C, Fleischer MichaelsenK & Frøkiær H (2006) Immunomodulating potential of supplementation with probiotics: A dose-response study in healthy young adults. FEMS Immunol Med Microbiol 47, 380-390.
10. Cross ML (2002) Microbes versus microbes: Immune signals generated by probiotic lactobacilli and their role in protection against microbial pathogens. FEMS Immunol Med Microbiol 34, 245-253.
11. Delzenne N, Cherbut C & Neyrinck A (2003) Prebiotics: Actual and potential effects in inflammatory and malignant colonic diseases. Curr Opin Clin Nutr Metab Care 6, 581-586.
12. Derynck R & Choy L (1998) Transforming growth factor-beta and its receptors. In The Cytokine Handbook, pp. 593-636 [AW Thomson, editor]. London: Academic Press.
13. Erickson KL & Hubbard NE (2000) Probiotic immunmodulation in health and disease. J Nutr 130, Suppl., 403S-409S.
14. Femia AP, Luceri C, Dolara P, Giannini A, Biggeri A, Salvadori M, Clune Y, Collins KJ, Paglierani M & Caderni G (2002) Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis 23, 1953-1960.
15. Flamm G, Glinsmann W, Kritchevsky D, Prosky L & Roberfroid M (2001) Inulin and oligofructose as dietary fiber: A review of the evidence. Crit Rev Food Sci Nutr 41, 353-362.
16. Fujiwara S, Akiyama M, Yamakido M, Seyama T, Kobuke K, Hakoda M, Kyoizumi S & Jones SL (1986) Cryopreservation of human lymphocytes for assessment of lymphocyte subsets and natural killer cytotoxicity. J Immunol Methods 90, 265-273.
17. Furrie E, MacFarlane S, Kennedy A, Cummings JH, Walsh SV, O'Neil DA & MacFarlane GT (2005) Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: A randomised controlled pilot trial. Gut 54, 242-249.
18. Gabrilovich D & Pisarev V (2003) Tumor escape from immune response: mechanisms and targets of activity. Curr Drug Targets 4, 525-536.
19. Gibson GR & Roberfroid M (1995) Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J Nutr 125, 1401-1412.
20. Gill HS & Cross ML (2002) Probiotics and immune function. In Nutrition and Immune Function, pp. 251-272 [PC Calder, CJ Field and HS Gill, editors]. Wallingford, UK: CABI International.
21. Gill HS, Rutherfurd KJ, Cross ML & Gopal PK (2001) Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN0191. Am J Clin Nutr 74, 833-839.
22. Guigoz Y, Rochat F, Perruisseau-Carrier G, Rochat I & Schiffrin EJ (2002) Effects of oligosaccharide on the faecal flora and nonspecific immune system in elderly people. Nutr Res 22, 13-25.
23. Hacker G, Redecke V & Hacker H (2002) Activation of the immune system by bacterial CpG-DNA. Immunology 105, 245-251.
24. Halpern GM, Vruwink KG, Vandewater J, Keen CL & Gershwin ME (1991) Influence of long-term yoghurt consumption in young-adults. Int J Immunother 7, 205-210.
25. Harris SG, Padilla J, Koumas L, Ray D & Phipps RP (2002) Prostaglandins as modulators of immunity. Trends Immunol 23, 144-150.
26. Kishi A, Uno K, Matsubara Y, Okuda C & Kishida T (1996) Effect of the oral administration of Lactobacillus brevis subsp coagulans on interferon-alpha producing capacity in humans. J Am Coll Nutr 15, 408-412.
27. Kvale D & Brandtzaeg P (1995) Constitutive and cytokine induced expression of HLA molecules, secretory component, and intercellular adhesion molecule-1 is modulated by butyrate in the colonic epithelial cell line HT-29. Gut 36, 737-742.
28. Lindsay JO, Whelan K, Stagg AJ, Gobin P, Al-Hassi HO, Rayment N, Kamm MA, Knight SC & Forbes A (2006) Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease. Gut 55, 348-355.
29. Marteau P, Seksik P & Jian R (2002) Probiotics and health: New facts and ideas. Curr Opin Biotechnol 13, 486-489.
30. Meydani SN & Ha WK (2000) Immunologic effects of yogurt. Am J Clin Nutr 71, 861-872.
31. Nagao F, Nakayama M, Muto T & Okumura K (2000) Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the immune system in healthy human subjects. Biosci Biotechnol Biochem 64, 2706-2708.
32. O'Gorman MR (2002) Evaluation of phagocytic cell function. In Manual of Clinical Laboratory Immunology, pp. 265-283 [NR Rose, RG Hamilton and B Detrick, editors]. Washington, DC: ASM Press.
33. Olivares M, Diaz-Ropero MP, Gomez N, Lara-Villoslada F, Sierra S, Maldonado JA, Martin R, Rodriguez JM & Xaus J (2006) The consumption of two new probiotic strains Lactobacillus gasseri CECT5714 and Lactobacillus coryniformis CECT5711, boosts the immune system of healthy humans. Int Microbiol 9, 47-52.
34. Ouwehand AC, Isolauri E, Kirjavainen PV, Tolkko S & Salminen SJ (2000) The mucus binding of Bifidobacterium lactis Bb12 is enhanced in the presence of Lactobacillus GG and Lact. delbrueckii subsp bulgaricus. Lett Appl Microbiol 30, 10-13.
35. Pasche B (2001) Role of transforming growth factor beta in cancer. J Cell Physiol 186, 153-168.
36. Perdigon GFR & Raya R (2002) Lactic acid bacteria and their effect on the immune system. Curr Issues Intest Microbiol 2, 27-42.
37. Pugh S & Thomas GAO (1994) Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E(2). Gut 35, 675-678.
38. Rafter J (2003) Probiotics and colon cancer. Best Pract Res Clin Gastroenterol 17, 849-859.
39. Rhind SG, Gannon GA, Suzui M, Shephard RJ & Shek PN (1999) Indomethacin inhibits circulating PGE2 and reverses postexercise suppression of natural killer cell activity. Am J Physiol 276, R1496-R1505.
40. Rigas B, Goldman IS & Levine L (1993) Altered eicosanoid levels in human colon-cancer. J Lab Clin Med 122, 518-523.
41. Roller M, Femia AP, Caderni G, Rechkemmer G & Watzl B (2004a) Intestinal immunity of rats with colon cancer is modulated by oligofructose-enriched inulin combined with Lactobacillus rhamnosus and Bifidobacterium lactis. Br J Nutr 92, 931-938.
42. Roller M, Rechkemmer G & Watzl B (2004b) Prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis modulates intestinal immune functions in rats. J Nutr 134, 153-156.
43. Sanderson IR (2004) Short chain fatty acid regulation of signaling genes expressed by the intestinal epithelium. J Nutr 134, suppl., 2450S-2454S.
44. Schley PD & Field CJ (2002) The immune-enhancing effects of dietary fibres and prebiotics. Br J Nutr 87, S221-S230.
45. Sheih YH, Chiang BL, Wang LH, Liao CK & Gill HS (2001) Systemic immunity-enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001. J Am Coll Nutr 20, suppl., 149-156.
46. Smyth MJ, Godfrey DI & Trapani JA (2001) A fresh look at tumor immunosurveillance and immunotherapy. Nature Immunol 2, 293-299.
47. Spanhaak S, Havenaar R & Schaafsma G (1998) The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans. Eur J Clin Nutr 52, 899-907.
48. van Loo J, Clune Y, Bennett M & Collins JK (2005) The SYNCAN project: goals, set-up, first results and settings of the human intervention study. Br J Nutr 93, Suppl. 1, S91-S98.
49. Watzl B, Girrbach S & Roller M (2005) Inulin, oligofructose and immunomodulation. Br J Nutr 93, Suppl. 1, S49-S55.
50. Yakar I, McIamed. R, Shakhar G, Shakhar K, Rosenne E, Abudarham N, Page GG & Ben-Eliyahu S (2003) Prostaglandin e(2) suppresses NK activity in vivo and promotes postoperative tumor metastasis in rats. Ann Surg Oncol 10, 469-479.